MRNA logo

Moderna (MRNA) Long Term Liabilities

Annual Total Long Term Liabilities

$1.56 B
-$255.00 M-14.07%

31 December 2023

MRNA Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$1.68 B
+$70.00 M+4.36%

30 September 2024

MRNA Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRNA Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-14.1%+4.0%
3 y3 years+302.3%+98.9%
5 y5 years+644.6%+775.8%

MRNA Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-14.1%+302.3%-7.6%+98.9%
5 y5 years-14.1%+644.6%-7.6%+775.8%
alltimeall time-14.1%>+9999.0%-7.6%>+9999.0%

Moderna Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$1.68 B(+4.4%)
June 2024
-
$1.60 B(+4.8%)
Mar 2024
-
$1.53 B(-1.6%)
Dec 2023
$1.56 B(-14.1%)
$1.56 B(-3.3%)
Sept 2023
-
$1.61 B(-11.1%)
June 2023
-
$1.81 B(+2.8%)
Mar 2023
-
$1.76 B(-2.7%)
Dec 2022
$1.81 B(+29.8%)
$1.81 B(+44.2%)
Sept 2022
-
$1.26 B(+0.9%)
June 2022
-
$1.25 B(-3.9%)
Mar 2022
-
$1.30 B(-7.2%)
Dec 2021
$1.40 B(+260.7%)
$1.40 B(+65.8%)
Sept 2021
-
$842.00 M(+38.3%)
June 2021
-
$609.00 M(+46.7%)
Mar 2021
-
$415.00 M(+7.2%)
Dec 2020
$387.00 M(+42.5%)
$387.00 M(-7.3%)
Sept 2020
-
$417.51 M(+10.6%)
June 2020
-
$377.47 M(+29.2%)
Mar 2020
-
$292.08 M(+7.6%)
Dec 2019
$271.50 M(+29.8%)
$271.50 M(+42.0%)
Sept 2019
-
$191.25 M(+3.5%)
June 2019
-
$184.74 M(-8.1%)
Mar 2019
-
$201.01 M(-3.9%)
Dec 2018
$209.10 M(-21.9%)
$209.10 M(-7.6%)
Sept 2018
-
$226.31 M(-15.5%)
Dec 2017
$267.73 M(-35.1%)
$267.73 M(>+9900.0%)
Sept 2017
-
$0.00(0.0%)
June 2017
-
$0.00(0.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$412.51 M(+8325.4%)
-
Dec 2016
-
$0.00(-100.0%)
Sept 2016
-
$2.47 M(-16.7%)
June 2016
-
$2.96 M(+4.3%)
Mar 2016
-
$2.84 M(-41.9%)
Dec 2015
$4.90 M(-58.0%)
$4.90 M(-18.8%)
Sept 2015
-
$6.03 M(-23.9%)
June 2015
-
$7.93 M(-19.4%)
Mar 2015
-
$9.84 M(-15.5%)
Dec 2014
$11.64 M(+35.6%)
$11.64 M(-34.8%)
Sept 2014
-
$17.86 M(+44.0%)
June 2014
-
$12.41 M(-26.8%)
Mar 2014
-
$16.95 M(+97.3%)
Dec 2013
$8.59 M(+15.2%)
$8.59 M(+31.8%)
Sept 2013
-
$6.51 M(+18.9%)
June 2013
-
$5.48 M(-3.7%)
Mar 2013
-
$5.69 M(-23.7%)
Dec 2012
$7.45 M(+5.4%)
$7.45 M(+54.6%)
Sept 2012
-
$4.82 M(-14.4%)
June 2012
-
$5.63 M(-33.0%)
Mar 2012
-
$8.41 M(+18.9%)
Dec 2011
$7.07 M(+17.9%)
$7.07 M(-11.3%)
Sept 2011
-
$7.98 M(-11.1%)
June 2011
-
$8.98 M(+154.7%)
Mar 2011
-
$3.52 M(-41.3%)
Dec 2010
$6.00 M
$6.00 M(-33.2%)
DateAnnualQuarterly
Sept 2010
-
$8.98 M(-21.9%)
June 2010
-
$11.51 M(-10.2%)
Mar 2010
-
$12.81 M(+42.6%)
Dec 2009
$8.98 M(+132.1%)
$8.98 M(-30.7%)
Sept 2009
-
$12.97 M(-1.7%)
June 2009
-
$13.19 M(+213.4%)
Mar 2009
-
$4.21 M(+8.7%)
Dec 2008
$3.87 M(-56.1%)
$3.87 M(-22.9%)
Sept 2008
-
$5.03 M(-16.7%)
June 2008
-
$6.03 M(-20.5%)
Mar 2008
-
$7.58 M(-14.1%)
Dec 2007
$8.83 M(-44.0%)
$8.83 M(-35.5%)
Sept 2007
-
$13.69 M(-7.5%)
June 2007
-
$14.79 M(-2.4%)
Mar 2007
-
$15.16 M(-3.9%)
Dec 2006
$15.77 M(+92.1%)
$15.77 M(+29.3%)
Sept 2006
-
$12.19 M(+12.5%)
June 2006
-
$10.84 M(+2.0%)
Mar 2006
-
$10.63 M(+29.5%)
Dec 2005
$8.21 M(+41.9%)
$8.21 M(+29.5%)
Sept 2005
-
$6.34 M(+9.8%)
June 2005
-
$5.77 M(+4.4%)
Mar 2005
-
$5.53 M(-4.4%)
Dec 2004
$5.78 M(+167.3%)
$5.78 M(-5.2%)
Sept 2004
-
$6.10 M(+158.3%)
June 2004
-
$2.36 M(+12.4%)
Mar 2004
-
$2.10 M(-2.9%)
Dec 2003
$2.16 M(-70.5%)
$2.16 M(+32.1%)
Sept 2003
-
$1.64 M(+8.8%)
June 2003
-
$1.50 M(-87.0%)
Mar 2003
-
$11.55 M(+57.3%)
Dec 2002
$7.34 M(>+9900.0%)
$7.34 M(+16.3%)
Sept 2002
-
$6.31 M(+106.7%)
June 2002
-
$3.06 M(+76.0%)
Mar 2002
-
$1.74 M(+5686.7%)
Dec 2001
$30.00 K(-3100.0%)
$30.00 K(-3100.0%)
Dec 1999
-$1000.00(-101.0%)
-$1000.00(-101.0%)
Sept 1999
-
$100.00 K(-200.0%)
June 1998
-
-$100.00 K(-200.0%)
Dec 1997
$100.00 K(0.0%)
$100.00 K(0.0%)
Sept 1997
-
$100.00 K(0.0%)
June 1997
-
$100.00 K(-200.0%)
Sept 1996
-
-$100.00 K(-200.0%)
June 1996
$100.00 K(0.0%)
$100.00 K(-50.0%)
Mar 1996
-
$200.00 K(0.0%)
Dec 1995
-
$200.00 K(0.0%)
Sept 1995
-
$200.00 K(+100.0%)
June 1995
$100.00 K(-80.0%)
$100.00 K(-66.7%)
Mar 1995
-
$300.00 K(0.0%)
Dec 1994
-
$300.00 K(0.0%)
Sept 1994
-
$300.00 K(-40.0%)
June 1994
$500.00 K
$500.00 K(0.0%)
Mar 1994
-
$500.00 K(0.0%)
Dec 1993
-
$500.00 K(-16.7%)
Sept 1993
-
$600.00 K

FAQ

  • What is Moderna annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Moderna?
  • What is Moderna annual total long term liabilities year-on-year change?
  • What is Moderna quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Moderna?
  • What is Moderna quarterly long term liabilities year-on-year change?

What is Moderna annual total long term liabilities?

The current annual total long term liabilities of MRNA is $1.56 B

What is the all time high annual total long term liabilities for Moderna?

Moderna all-time high annual total long term liabilities is $1.81 B

What is Moderna annual total long term liabilities year-on-year change?

Over the past year, MRNA annual total long term liabilities has changed by -$255.00 M (-14.07%)

What is Moderna quarterly total long term liabilities?

The current quarterly long term liabilities of MRNA is $1.68 B

What is the all time high quarterly long term liabilities for Moderna?

Moderna all-time high quarterly total long term liabilities is $1.81 B

What is Moderna quarterly long term liabilities year-on-year change?

Over the past year, MRNA quarterly total long term liabilities has changed by +$65.00 M (+4.04%)